Emerging Infectious Diseases (Jul 2010)

Extensive Drug Resistance in Malaria and Tuberculosis

  • Chansuda Wongsrichanalai,
  • Jay K. Varma,
  • Jonathan J. Juliano,
  • Michael E. Kimerling,
  • John R. MacArthur

DOI
https://doi.org/10.3201/eid1607.091840
Journal volume & issue
Vol. 16, no. 7
pp. 1063 – 1067

Abstract

Read online

Drug resistance in malaria and in tuberculosis (TB) are major global health problems. Although the terms multidrug-resistant TB and extensively drug-resistant TB are precisely defined, the term multidrug resistance is often loosely used when discussing malaria. Recent declines in the clinical effectiveness of antimalarial drugs, including artemisinin-based combination therapy, have prompted the need to revise the definitions of and/or to recategorize antimalarial drug resistance to include extensively drug-resistant malaria. Applying precise case definitions to different levels of drug resistance in malaria and TB is useful for individual patient care and for public health.

Keywords